No abstract available
Keywords:
GLP‐1 receptor agonists; diabetes mellitus; hypertrophy; muscle atrophy; obesity; skeletal muscle.
MeSH terms
-
Anti-Obesity Agents* / pharmacology
-
Anti-Obesity Agents* / therapeutic use
-
Diabetes Mellitus, Type 2*
-
Glucagon-Like Peptide-1 Receptor
-
Glucagon-Like Peptides / therapeutic use
-
Humans
-
Hypoglycemic Agents
-
Muscles
Substances
-
semaglutide
-
Anti-Obesity Agents
-
Glucagon-Like Peptides
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents